Mark Rees - Xero Chief Officer
0XE Stock | EUR 101.00 1.00 0.98% |
Insider
Mark Rees is Chief Officer of Xero
Phone | 64 4 819 4800 |
Web | https://www.xero.com |
Xero Management Efficiency
The company has return on total asset (ROA) of 0.0211 % which means that it generated a profit of $0.0211 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0191) %, meaning that it generated substantial loss on money invested by shareholders. Xero's management efficiency ratios could be used to measure how well Xero manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Thomas Lindegaard | Scandinavian Tobacco Group | N/A | |
Mette Valentin | Scandinavian Tobacco Group | N/A | |
Junichi Fukuchi | Japan Tobacco | N/A | |
Lars Wassberg | Scandinavian Tobacco Group | N/A | |
Spencer JD | PDS Biotechnology Corp | N/A | |
Dermot Crowley | Dalata Hotel Group | 56 | |
Nathalie Riebel | PDS Biotechnology Corp | N/A | |
Adrian Sherry | Dalata Hotel Group | N/A | |
Otis Brawley | PDS Biotechnology Corp | 58 | |
Des McCann | Dalata Hotel Group | N/A | |
Simon Augustesen | Scandinavian Tobacco Group | N/A | |
Masamichi Terabatake | Japan Tobacco | 58 | |
Matthew CPA | PDS Biotechnology Corp | 54 | |
Mutsuo Iwai | Japan Tobacco | 63 | |
Nobuya Kato | Japan Tobacco | N/A | |
Gregory Conn | PDS Biotechnology Corp | 68 | |
DeLyle Bloomquist | PDS Biotechnology Corp | 60 | |
Naohiro Minami | Japan Tobacco | 59 | |
Sanjay Zaveri | PDS Biotechnology Corp | N/A | |
Lauren MD | PDS Biotechnology Corp | 63 | |
Ilian Iliev | PDS Biotechnology Corp | 43 |
Management Performance
Return On Equity | -0.0191 | |||
Return On Asset | 0.0211 |
Xero Leadership Team
Elected by the shareholders, the Xero's board of directors comprises two types of representatives: Xero inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Xero. The board's role is to monitor Xero's management team and ensure that shareholders' interests are well served. Xero's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Xero's outside directors are responsible for providing unbiased perspectives on the board's policies.
Steven BE, Chief Officer | ||
Rachael Powell, Chief People Officer | ||
Anna Curzon, Chief Partner Officer | ||
Nicole Reid, Chief Officer | ||
BEc FCIS, Company Officer | ||
Rod Drury, Founder Director | ||
Mark Rees, Chief Officer | ||
Toby CFA, Head Relations | ||
Kirsty GodfreyBilly, Chief Officer | ||
Damien Tampling, Chief Officer |
Xero Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Xero a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.0191 | |||
Return On Asset | 0.0211 | |||
Profit Margin | (0.02) % | |||
Operating Margin | 0.07 % | |||
Current Valuation | 7.36 B | |||
Shares Outstanding | 151.68 M | |||
Shares Owned By Insiders | 16.07 % | |||
Shares Owned By Institutions | 27.41 % | |||
Price To Book | 11.84 X | |||
Price To Sales | 5.62 X |
Currently Active Assets on Macroaxis
BTC | Bitcoin | |
TRX | TRON | |
BNB | Binance Coin | |
ADA | Cardano | |
XRP | XRP |
Other Information on Investing in Xero Stock
Xero financial ratios help investors to determine whether Xero Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Xero with respect to the benefits of owning Xero security.